
AI-generated summary
Heron Technology is an overall solution provider for boron neutron capture therapy and actively promotes equipment construction and market expansion at home and abroad.
Herongke management team (file photo)
[Reporter Chen Yongji/Taipei Report] Boron Neutron Capture Therapy (BNCT) overall solution provider Heron Technology (7799) announced today (15th) that it successfully bid for approximately 2.19 hectares of land in the Miaoli High-speed Railway Special Zone Industrial Zone for 1.555 billion yuan. In the future, it plans to build a high-end medical accelerator R&D and manufacturing and drug R&D base to strengthen core technology, equipment manufacturing and drug development capabilities. Heronco said that this investment demonstrates Heronco’s determination to deeply explore Taiwan and expand its long-term layout. It also echoes the national policy of autonomy of key medical equipment and is an important milestone in promoting the commercialization of global BNCT.
As the global demand for precision cancer treatment continues to grow, Heronco actively promotes the construction and market expansion of BNCT equipment at home and abroad, and plans to expand R&D and manufacturing capacity at its Miaoli base. In the future, BNCT technology will be used as the starting point to build a cross-field precision medical research and development platform. The localization of high-end medical accelerators is also one of the main development directions, covering functions such as core technology research and development, precision equipment manufacturing, system assembly integration and testing verification, and in response to the rigid demand for BNCT in the future international cancer medical market.
In the field of drugs, we will plan the development space for relevant R&D and process technology. In addition to continuing to deepen the development of BNCT treatment and diagnostic drugs, we will conduct R&D and production line layout in stages according to market demand, complementing the existing industrial cooperation system and strengthening long-term supply chain stability. In addition to continuing to improve BNCT's comprehensive solutions, Heronco also builds a research and development platform based on BNCT to connect accelerator technology and nuclear medicine pharmaceuticals in series to form an ecosystem of high-end precision cancer treatment.
In recent years, Herongke has continued to promote the construction, clinical application and international strategic cooperation of BNCT treatment centers at home and abroad. As the global market gradually expands, the demand for medical accelerator equipment, therapeutic drugs and system maintenance services continues to increase. In the future, we will continue to use Taiwan as the core R&D and manufacturing base, combine independent technology, industrial cooperation and international market layout, improve the BNCT industry ecosystem, promote Taiwan's independently developed advanced cancer treatment technology to the world, and create an internationally competitive high-end medical technology industry platform.
AI outlook — possibilities, not facts
The Miaoli base will plan to build a high-end medical accelerator R&D and manufacturing and drug R&D base
Very likely · Within months

In response to the dispute over the relocation of Songji, Pegatron Chairman Tong Zixian expressed his opposition and suggested that the AI park be located in Danhai New Town. Minister of Economic Affairs Gong Mingxin said that it is difficult to reach a consensus on the relocation of Songji in the short term, and the Danhai New Town has transportation, water, electricity and land conditions, which is indeed a good idea.

Yushan Financial Holdings announced its own profit in September 2026, which was the first time it announced profits after merging with Sanshangshou. The cumulative net profit after tax for the first nine months reached 31.85 billion yuan, an annual increase of 21.54%, and the net profit after tax per share (EPS) was 1.95 yuan, a record high.
The 140th Canton Fair opened in Guangzhou on the 15th, and the Baiyun Airport port has experienced peak passenger flow since October 10th. On the 14th, the number of foreigners entering the country in a single day exceeded 20,000, accounting for 73.4% of the total arrivals. The border inspection department took a number of measures to ensure efficient customs clearance.

Zhengwen Technology announced the establishment of a strategic cooperation with Starman New Photonics, with an initial investment of US$15 million to establish a joint venture in the United States, focusing on the production of 800G and 1.6T optical transceivers to seize business opportunities in AI data centers.

Korean media columns warned that due to the impact of global memory production expansion and China's mass production of RAM in 2028, South Korea only has a golden window of 2 to 3 years left. If new growth industries are not prepared in time, we may face the risk of economic reversal due to oversupply in 2029.
The 2026 Shanghai Derivatives Market Forum was held in Shanghai on the 15th, with the theme of accelerating the high-quality development of the derivatives market during the "15th Five-Year Plan" period. Relevant persons in charge from the China Securities Regulatory Commission, Shanghai Futures Exchange, and China Financial Futures Exchange attended and delivered speeches on key tasks such as risk prevention, serving the real economy, and high-level opening up.